Clinical Trial Update: Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial to evaluate safety, efficacy, and pharmacokinetics of Budesonide Extended-Release Tablets in pediatric patients aged 5 to 17 with active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Budesonide Extended-Release Tablets (budesonide)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Ulcerative Colitis | Phase 4 | Status: RECRUITING